A randomized trial comparing cyclosporine and steroids with cyclosporine, azathioprine, and steroids in cadaveric renal transplantation

Transplantation

Volumn 65, Issue 5, 1998, Pages 653-661

  Amenábar, Juan José ^a   Gómez Ullate, Pablo ^a   García López, Fernando J ^b   Aurrecoechea, Begoña ^a   García Erauzkin, Gorka ^a   Lampreabe, Ildefonso ^a  

^a HOSPITAL DE CRUCES   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; OKT 3; PREDNISONE; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CADAVER KIDNEY; CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AZATHIOPRINE; CYCLOSPORINE; DISEASE-FREE SURVIVAL; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDNISONE; REGRESSION ANALYSIS; TIME FACTORS;

EID: 0345267267     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199803150-00009     Document Type: Article

References (39)

1. Opelz G. Collaborative transplant study: 10-year report. Transplant Proc 1992; 24: 2342.
2. Fries D, Kechrid C, Charpentier B, Hammouche M, Moulin B. A prospective study of a triple association: cyclosporine, corticosteroids, and azathioprine in immunologically high-risk renal transplantation. Transplant Proc 1985; 17: 1231.
3. Illner WD, Land W, Habersetzer R, et al. Cyclosporine in combination with azathioprine and steroids in cadaveric renal transplantation. Transplant Proc 1985; 17: 1181.
4. Slapak M, Geoghegan T, Digard N, Ahmed K, Sharman VL, Crocket R. The use of low-dose cyclosporine in combination with azathioprine and steroids in renal transplantation. Transplant Proc 1985; 17: 1222.
5. Fassbinder W, Brunner FP, Brynger H, et al. Combined report on regular dialysis and transplantation in Europe, XXD, 1989. Nephrol Dial Transplant 1991; 6 (suppl 1): 5.
6. Ponticelli C, Tarantino A, Montagnino G, et al. A randomized trial comparing triple-drug and double-drug therapy in renal transplantation. Transplantation 1988; 45: 913.
7. Montagnino G, Tarantino A, Banfi G, Aroldi A, Cesana B, Ponticelli C. A randomized trial comparing triple-drug and double-drug therapy in renal transplantation. Transplantation 1994; 58: 149.
8. Brinker KR, Dickerman RM, Gonwa TA, et al. A randomized trial comparing double-drug and triple-drug therapy in primary cadaveric renal transplants. Transplantation 1990; 50: 43.
9. Lindholm A, Albrechtsen D, Tufveson G, Karlberg I, Persson NH, Groth CG. A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation. Transplantation 1992; 54: 624.
10. Hardie IR, Tiller DJ, Mahony JF, et al. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomized trial comparing cyclosporine + prednisolone with cyclosporine + azathioprine and with triple therapy in cadaveric renal transplantation. Transplant Proc 1993; 25: 583.
11. Ponticelli C, Tarantino A, Segoloni G, et al. A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation. J Am Soc Nephrol 1997; 8: 638.
12. Lindholm A, Albrechtsen D, Flatmark A, et al. A randomized multicenter trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone following primary living donor renal transplantation. Transpl Int 1994; 7: 207.
13. Kunz R, Neumayer H-H. Maintenance therapy with triple versus double immunosuppressive regimen in renal transplantation: a meta-analysis. Transplantation 1997; 63: 386.
14. Don S, Kopecky KK, Tuli MM, Siddiqui AR. Detection of rejection in renal allografts: evaluation with duplex sonography and DTPA renal scintigraphy with kidney/aorta perfusion ratios. J Ultrasound Med 1990; 9: 503.
15. Gifford RR, Neumyer MM, Yang HC, Escobar FS, Thiele BL. Successful identification of acute renal allograft rejection with duplex ultrasonography. Clin Transplant 1994; 8: 40.
16. Paul LC, Hayry P, Foegh M, et al. Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: joint proposal from the Fourth Alexis Carrel Conference on Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs. Transplant Proc 1993; 25: 2022.
17. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
18. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985; 27: 58.
19. Blackwelder WC, Chang MA. Sample size graphs for proving the null hypothesis. Control Clin Trial 1984; 5: 97.
20. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley and Sons, 1989.
21. McCullagh P, Neider JA. Generalized linear models, 2nd ed. London: Chapman and Hall, 1989.
22. Rochon J, Aprile MA, Cardella CJ. Analyzing the number of "rejection episodes" in renal transplant studies. Transplantation 1992; 53: 1236.
23. Francis B, Green M, Payne C, eds. GLIM 4: the statistical system for generalized linear interactive modelling. Release 4 manual. Oxford: Oxford University Press, 1994.
24. Restifo AC, Petrie JJB, Rigby RJ, et al. A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low-risk, first cadaveric renal allograft recipients. Transplant Proc 1989; 21: 1604.
25. Bowman JS III, Angstadt JD, Waymack JP, Jaffersson GJ. A comparison of triple-therapy with double-therapy immunosuppression in cadaveric renal transplantation. Transplantation 1992; 53: 556.
26. Carmellini M, Romagnoli J, Pietrabissa A, et al. Double-therapy versus triple-therapy immunosuppression in cadaveric renal transplants. Transplant Proc 1994; 5: 2546.
27. Vanderwerf BA, Serota AI. Low-dose cyclosporine for cadaveric renal transplantation. Transplantation 1988; 45: 320.
28. Schleibner S, Welter H, Abendroth D, et al. Renal transplantation at the Munich Transplant Center: a retrospective single-center review. In: Terasaki PI, ed. Clinical transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1988: 107.
29. Pallardó LM, Sánchez J, García J, et al. Five-year experience with a triple drug protocol in renal transplantation. Transplant Proc 1992; 24: 56.
30. Isoniemi HM, Ahonen J, Tikkanen MJ, et al. Long-term consequences of different immunosuppressive regimens for renal allografts. Transplantation 1993; 55: 494.
31. Canafax DM, Min DI, Matas AJ, et al. Effects of initial cyclosporine dose and timing on long-term creatinine levels in cadaver renal transplantation. Clin Transplant 1990; 4: 321.
32. Almond PS, Gillingham KJ, Sibley R, Moss A, Melin M, Leventhal J. Renal transplant function after ten years of cyclosporine. Transplantation 1992; 53: 316.
33. Ferguson R. Acute rejection episodes: best predictor of long-term primary cadaveric renal transplant survival. Clin Transplant 1994; 8: 328.
34. Tesi RJ, Henry ML, Elkhammas EA, Ferguson RM. Predictors of long-term primary cadaveric renal transplant survival. Clin Transplant 1993; 7: 345.
35. Gulanikar AC, MacDonald AS, Sungurtekin U, Belitsky P. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants. Transplantation 1992; 53: 323.
36. Kasiske BL, Massy ZA, Guijarro C, Ma JZ. Chronic renal allograft rejection and clinical trial design. Kidney Int 1995; 48 (suppl 52): 116.
37. Jones RM, Murie JA, Allen RD, Ting A, Morris PJ. Triple therapy in cadaver renal transplantation. Br J Surg 1988; 75: 4.
38. Sollinger HW for The U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225.
39. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Blinded randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61: 1029.